Aclarion PE Ratio 2021-2024 | ACON
Current and historical p/e ratio for Aclarion (ACON) from 2021 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aclarion PE ratio as of February 21, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Aclarion PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-21 | 5.11 | 0.00 | |
| 2024-09-30 | 0.18 | $-246.67 | 0.00 |
| 2024-06-30 | 0.29 | $-836.67 | 0.00 |
| 2024-03-31 | 0.33 | $-1,746.67 | 0.00 |
| 2023-12-31 | 0.20 | $-2,400.00 | 0.00 |
| 2023-09-30 | 0.33 | $-2,400.00 | 0.00 |
| 2023-06-30 | 0.69 | $-1,760.00 | 0.00 |
| 2023-03-31 | 0.65 | $-800.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.000B |
| Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.052B | 27.37 |
| Elevance Health (ELV) | United States | $90.846B | 11.88 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| Natera (NTRA) | United States | $22.788B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Revvity (RVTY) | United States | $13.997B | 23.47 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| ModivCare (MODV) | United States | $0.082B | 4.46 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |